Grant: Discovery Grants Program - Individual
Simon Fraser University
$45,000.00
New avenues in bioinorganic chemistry: catalysis in vivo, and bimetallic systems for small-molecule transformations
FY 2012-13
Summary
This interdisciplinary inorganic chemistry research program is directed in two different areas: (1) the use of endogenous catalysts in the brain to promote the synthesis of diagnostic and therapeutic molecules for treating neurodegenerative disease and (2) the development of catalysts containing two metal centers in close proximity to promote selective small-molecule oxidative transformations. Essential to this research is the study of how metal ions either in vivo or in designed coordination environments interact with substrates and perform in catalytic applications.
(1) The increased incidence of neurodegenerative disease, in particular Alzheimer's disease (AD), and the lack of effective treatment strategies, makes this a very important research area. While the cause(s) of many of these diseases remain elusive, the build-up of redox-active transition metals is strongly linked to the etiology of AD. This research program aims to study the speciation of dysregulated metal ions, their interaction with specific biomolecules, and their ability to act as catalysts for molecular transformations. Working at the interface of inorganic chemistry and biology, this project offers opportunities to collaborate across disciplines to investigate innovative treatment strategies.
(2) We plan to develop compounds capable of catalyzing the selective incorporation of oxidized functions into organic molecules. Bimetallic systems have great potential to promote this chemistry, often exhibiting reactivity not available to their monometallic counterparts. This unique reactivity can be in part ascribed to enhanced substrate binding, stabilization of reactive intermediates, and the presence of two metal ions in close proximity. Harnessing these features to promote specific small-molecule transformations will require detailed knowledge of the geometrical and electronic structure of the studied systems. By a combination of spectroscopy, calculations, and reactivity studies, we aim to develop new and efficient catalytic systems with diverse applications.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
371598-2009
Name nom
Storr, Timothy
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
45000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3600
Research subject group en
Inorganic chemistry
Research subject group fr
Chimie inorganique
Research subject en
Inorganic chemistry
Research subject fr
Chimie inorganique
Partie
4
Nb partie
5
Application title
New avenues in bioinorganic chemistry: catalysis in vivo, and bimetallic systems for small-molecule transformations
Keyword
NSERC
Application summary
This interdisciplinary inorganic chemistry research program is directed in two different areas: (1) the use of endogenous catalysts in the brain to promote the synthesis of diagnostic and therapeutic molecules for treating neurodegenerative disease and (2) the development of catalysts containing two metal centers in close proximity to promote selective small-molecule oxidative transformations. Essential to this research is the study of how metal ions either in vivo or in designed coordination environments interact with substrates and perform in catalytic applications.
(1) The increased incidence of neurodegenerative disease, in particular Alzheimer's disease (AD), and the lack of effective treatment strategies, makes this a very important research area. While the cause(s) of many of these diseases remain elusive, the build-up of redox-active transition metals is strongly linked to the etiology of AD. This research program aims to study the speciation of dysregulated metal ions, their interaction with specific biomolecules, and their ability to act as catalysts for molecular transformations. Working at the interface of inorganic chemistry and biology, this project offers opportunities to collaborate across disciplines to investigate innovative treatment strategies.
(2) We plan to develop compounds capable of catalyzing the selective incorporation of oxidized functions into organic molecules. Bimetallic systems have great potential to promote this chemistry, often exhibiting reactivity not available to their monometallic counterparts. This unique reactivity can be in part ascribed to enhanced substrate binding, stabilization of reactive intermediates, and the presence of two metal ions in close proximity. Harnessing these features to promote specific small-molecule transformations will require detailed knowledge of the geometrical and electronic structure of the studied systems. By a combination of spectroscopy, calculations, and reactivity studies, we aim to develop new and efficient catalytic systems with diverse applications.